From one of the largest educational and scientific events in the oncology community, we had the chance to sit down with a few prostate cancer experts to hear the latest news coming out of the ASCO 2017 conference. The panel included the following experts:
- Philip Kantoff, MD, Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center
- Daniel Petrylak, MD, Director, Genitourinary Oncology, Co-Director, Signal Transduction Research Program, Yale University Cancer Center
- Sumit Subudhi, MD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of CancerMedicine, The University of Texas MD Anderson Cancer Center
- Darryl Mitteldorf, LCSW, Executive Director, Malecare
The panel covers a variety of headline topics such as treatment options, prognostic factors, genetic marker, clinical trials, and more. Check out the full video to below to hear from four prostate cancer experts.